Jim Heal, Pharmacist
Director of Pharmacy
Carlos G. Otis Health Care Center, Inc.
PO Box 216
Townshend, Vermont 05353
Tel: 1-802-365-3624
Fax: 1-802-365-9500
email: jh...@gracecottage.org
This email message may contain privileged and/or confidential information. If you are not the intended recipient(s), you are hereby notified that any dissemination, distribution, or copying of this email message is strictly prohibited. If you have received this message in error, please immediately notify the sender and delete this email message from your computer.
Meggan Owens, Pharm.D.
Medication Safety Pharmacist
Riverside Methodist Hospital
Columbus, Ohio 43214
Phone: 566-5888
______________________________ _________________
FORTUNE "100 Best Companies to Work for 2008 "
From:
"Thompson, Karen \(Anchorage\)" <Karen.Thomp...@providence.org >
Karen E. Thompson, Pharm.D.
Medication Safety Officer
Providence Alaska Medical Center
phone 907-212-4826
fax 907-261-3645
"We must accept human error as inevitable - and design around that
Tram Emily Do, Pharm.D.
Medication Safety Pharmacist
Department of Pharmacy Services
Riverside County Regional Medical Center
26520 Cactus Avenue
Moreno Valley, California 92555
Please let me know.
- How are multiple charges avoided?
- Is the program shared with patients?
- Do patients have the ability to opt out of the redispensing program?
Paul Kociemba RPh, MS
Bar Code Pharmacy Administrator
We just implemented an MDI redispensing program. The process has been
approved by our infection control department. The only inhalers we
redispense are albuterol and flovent. The is a lengthy process for
redispensation including - tracking and cleaning. Spacer use is
MANDATORY for redispensed inhalers.
Thanks
Donna Bohannon, R. Ph.
Medication Safety Officer
Franklin Square Hospital
443-777-7948
B- 410-932-7371
"Thompson, Karen \(Anchorage\)" <Karen.Thomp...@providence.org >
Sent by: ASMSO@googlegroups.com
03/23/2009 01:19 PM
Following two incidents of patients receiving nalbuphine in our L&D
department while being treated with buprenorphine (Subutex), which
precipitated withdrawal, we are currently looking to make our
practices with these drugs safer. Do any of you have experience with
similar issues? Any informational documents you utilized? What kind
Deb Saine, MS, RPh
Medication Safety Manager
Winchester Medical Center
Winchester, VA 22601
Phone: 540-536-2017
DSa...@ValleyHealthLink.com <mailto:DSa...@ValleyHealthLin k.com>
Rxcellence: Achieving the best use of medications through leadership, teamwork, and innovation.
thanks
Karen E. Thompson, Pharm.D.
Medication Safety Officer
Providence Alaska Medical Center
phone 907-212-4826
Does anyone have PCA Protocal & Moderate/Conscious Sedation Protocals
& P&P that they wouldn't mind sharing?
Thank you,
Rosemarie Salo, Pharm.D.
Medication Safety & Compliance Officer, Pharmacy Services
University of California Irvine Healthcare
101 The City Drive, Route 32 │Second Floor, Bldg 53, Room 211
Thanks!
Judy J
Judy Stover, RPh
Medication Safety Coordinator
317.338.6854, pager 1700
St. Vincent Hospital & Health Care System
JCSto...@stvincent.org <mailto:JCSto...@stvincent.org >
Tram Emily Do, Pharm.D.
Medication Safety Pharmacist
Department of Pharmacy Services
Riverside County Regional Medical Center
26520 Cactus Avenue
Moreno Valley, California 92555
3/23/2009 10:19 AM >>>
Gary Ostrowski, Pharm.D.
Medication Safety Officer & Medication Regulations
Pharmacy Services
Saint Joseph Hospital
Orange, CA 92868
(714) 771-8067
Medication events and medication safety issues that are documented in the incident reporting system are not forgotten. They remain as reminders that action needs to be taken. Medication events and medication safety issues that are not documented are soon forgotten and are at risk of occurring over and over again.